Douglas Tsao

Sell-Side Remains Optimistic On Sage Therapeutics Despite Depression Drug Disappointment

Barclays: Impax Labs-Amneal Pharma Merger Creates A Generics Leader

Barclays: Mallinckrodt's Sucampo Deal Overshadowed By Competitive Threats

Barclays: Impax Labs-Amneal Pharma Merger Creates A Generics Leader

Barclays: Mallinckrodt's Sucampo Deal Overshadowed By Competitive Threats

Barclays Injects Allergan With An Upgrade, Says Valuation Model Has Improved

Here's Why Barclays Downgraded Mallinckrodt

Barclays Injects Allergan With An Upgrade, Says Valuation Model Has Improved

Here's Why Barclays Downgraded Mallinckrodt

Teva Pharmaceuticals Hit With A Slew Of Downgrades Following Guidance Revision

In Order To Make A Turnaround, Valeant Will Need To Go Back To Basics